Month: April 2013

Michael J. Fox Foundation Awards an Additional Grant for Nrf2 Research

[et_pb_section bb_built=”1″ _builder_version=”3.0.47″ next_background_color=”#224672″][et_pb_row _builder_version=”3.0.47″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”4_4″][et_pb_text _builder_version=”3.0.106″] Our original article highlighting the Michael J. Fox Foundation’s interest in NRF2 activation solutions for Parkinson’s disease met with a lot of interest, so we decided to do a follow …

Read MoreMichael J. Fox Foundation Awards an Additional Grant for Nrf2 Research

What Tecfidera Tells Us About the Size of the Nrf2 Medical and Supplementation Market

[et_pb_section fb_built=”1″ _builder_version=”3.0.47″][et_pb_row _builder_version=”3.0.47″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” custom_padding=”0|0px|27px|0px”][et_pb_column type=”4_4″ _builder_version=”3.0.47″ parallax=”off” parallax_method=”on”][et_pb_text _builder_version=”3.0.47″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”]According to an article published by Foxnews entitled ” FDA approves new oral MS drug, Tecfidera” the following information reveals just how big the market …

Read MoreWhat Tecfidera Tells Us About the Size of the Nrf2 Medical and Supplementation Market